Racial differences in scleroderma among women in michigan timothy J. Laing, Brenda W. Gillespie, Mary B. Toth, Maureen D. Mayes

Arthritis and Rheumatism

Volumn 40, Issue 4, 1997, Pages 734-742

  Gallavan Jr , Robert H ^a,c   Burns, Carol J ^a   Johanns, Jewel R ^a   Cooper, Brenda C ^b   Keroack, Brian J ^b   Wasko, Mary Chester M ^b   Lacey Jr , James V ^a   Schottenfeld, David ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646759966     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Silman AJ, Hochberg MC: Scleroderma. In, Epidemiology of the Rheumatic Diseases. Edited by AJ Silman, MC Hochberg. Oxford, Oxford University Press, 1993
2. Medsger TA Jr, Steen VD: Classification, prognosis. In, Systemic Sclerosis. Edited by PJ Clements, DE Furst. Baltimore, Williams and Wilkins, 1996
3. Steen V, Conte C, Santoro D, Casterline GLZ, Oddis CV, Medsger TA Jr: Twenty-year incidence survey of systemic sclerosis (abstract). Arthritis Rheum 31 (suppl 4):S57, 1988
4. Medsger TA Jr, Masi AT: Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74:714-721, 1971
5. Hochberg MC, Lopez-Acuna D, Gittelsohn AM: Mortality from systemic sclerosis (scleroderma) in the United States, 1969-1977. In, Current Topics in Rheumatology. Systemic Sclerosis (Scleroderma). Edited by CM Black, AR Myers. New York, Gower Medical Publishing, 1985
6. Schottenfeld D, Burns CI, Gillespie BW, Laing TJ, Mayes MD, Heeringa SG, Alcser KH: The design of a population-based case-control study of systemic sclerosis (scleroderma): commentary on the University of Michigan Study. J Clin Epidemiol 48:583-586, 1995
7. Hook EB, Regal RR: Effect of variation in probability of ascertainment by source (variable catchability) upon capture-recapture estimates of prevalence. Am J Epidemiol 137:1148-1166, 1993
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590, 1980
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
10. Hirschenberger W: The validity of death certificates among documented scleroderma cases in Metropolitan Detroit (thesis). Ann Arbor, University of Michigan School of Public Health, 1995
11. Office of the State Registrar and Center for Health Statistics: Michigan Health Statistics. Lansing, MI, Michigan Department of Public Health, 1993
12. Cox DR: Regression models and life tables (with discussion). J Royal Stat Soc B 74:187-220, 1972
13. Lawless JF: Statistical Models and Methods for Lifetime Data. New York, John Wiley and Sons, 1982
14. Reveille JD, Durban E, Goldstein R, Moreda R, Arnett FC: Racial differences in the frequencies of scleroderma-related auto-antibodies. Arthritis Rheum 35:216-218, 1992
15. Vayssairat M, Baudot N, Abuaf N, Johanet C: Long-term follow-up study of 164 patients with definite systemic sclerosis: classification considerations. Clin Rheumatol 11:356-363, 1992
16. McNeilage LJ, Youngchaiyud U, Whittingham S: Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 32:54-60, 1989
17. Tan FK, Howard RF, Reveille JD, Moulds JM, Paxton G, Arnett FC: Case control study of systemic sclerosis among Choctaw native Americans in southeastern Oklahoma (abstract). Arthritis Rheum 37 (suppl 9):S282, 1994
18. Tamaki T, Mori S, Takehara K: Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 283:366-371, 1991
19. Barnett AJ: Scleroderma. In, Progressive Systemic Sclerosis. Ed ited by IN Kugelmass. Springfield, IL, Charles C. Thomas, 1974
20. Silman A, Jannini S, Symmons D, Bacon P: An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 27:286-290, 1988
21. Michel Cl, McKenna CH, Elveback LR, Kaslow RA, Kurland LT: Epidemiology of systemic lupus erythematosus and other connective tissue disease in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc.60:105-113, 1985
22. Medsger TA Jr, Steen V: Systemic sclerosis and related syndromes: clinical features and treatments. In, Primer on the Rheumatic Diseases. Edited by HR Schumacher, JH Klippel, WJ Koopman. Atlanta, Arthritis Foundation, 1993
23. Seibold JR: Systemic sclerosis: clinic features. In, Rheumatology. Edited by JH Klippel, PA Dieppe. St. Louis, Mosby, 1994
24. Agresti A: Categorical Data Analysis. New York, John Wiley and Sons, 1990
25. Masi AT, D'Angelo WA: Epidemiology of fatal systemic sclerosis (diffuse scleroderma): a 15-year survey in Baltimore. Ann Intern Med 66:870-883, 1967
26. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H: Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 75:369-376, 1971
27. Medsger TA Jr, Masi AT: Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis 26:647-660, 1973
28. Medsger TA Jr, Masi AT: The epidemiology of systemic sclerosis (scleroderma) among male U.S. veterans. J Chronic Dis 31:73-85, 1978
29. Altman RD, Medsger TA Jr, Bloch DA, Michel BA: Predictors of survival in systemic sclerosis (scleroderma). Arthritis Rheum 34:403-413, 1991
30. Bennett R, Bluestone R, Holt PLJ, Bywaters EGL: Survival in scleroderma. Ann Rheum Dis 30:581-588, 1971
31. Farmer RG, Gifford RW Jr, Hines EA: Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma: a study of 271 cases. Circulation XXI:1088-1095, 1960
32. Lee P, Langevitz P, Alderdice CA, Aubrey M, Baer PA, Baron M, Buskila D, Dutz JP, Khostanteen I, Piper S, Ramsden M, Rosenbach TO, Sukenik S, Wilkinson S, Keyston EC: Mortality in systemic sclerosis (scleroderma). QJM 82:139-148, 1992
33. Wynn J, Fineberg N, Matzer L, Cortada X, Armstrong W, Dillon JC, Kinney EL: Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 110:123-127, 1985
34. Sackner MA: Scleroderma. New York, Grune and Stratton, 1966